Battle of the Flea & Tick Preventives: Oral vs. Injectable in the Philippine Veterinary Market

The Showdown: NexGard (Plain & Spectra) vs. Bravecto 365 Injectable

As the Philippine veterinary industry continues to modernize, veterinarians are increasingly presented with new options in flea and tick prevention. Two major contenders dominate the market:

  • NexGard® / NexGard Spectra® (Boehringer Ingelheim) – oral chewables
  • Bravecto® 365 Injectable (MSD Animal Health) – long-acting injectable

Globally, both have made significant market strides. But the question is: which formulation will dominate the Philippine market in 2025 and beyond?

Advertisements & Promos

Global Market Trends

  • United States & Australia: Oral preventives remain the most popular, with NexGard leading. Pet owners prefer monthly administration due to familiarity and control.
  • Europe: A growing trend toward long-acting injectables like Bravecto 365 is being observed, particularly among working pet owners and multi-pet households.
  • Southeast Asia: Markets like Thailand and Malaysia show early signs of injectable preference due to lower compliance burdens and longer efficacy periods.
  • Philippine prediction: A shift toward injectables is highly likely, especially in urban clinics catering to busy pet owners—though chewables will retain strong market share due to client familiarity and flexibility.

Comparison: NexGard/Spectra vs. Bravecto 365

Pros and Cons Summary:

NexGard / Spectra

Pros:

  • Familiar and trusted by many owners
  • Monthly control allows vet-patient interaction
  • Spectra covers broader parasites (heartworm, roundworms)

Cons:

  • Missed doses = exposure
  • May cause GI upset in sensitive dogs
  • Monthly cost commitment

Bravecto 365 Injectable

Pros:

  • Once-a-year convenience
  • Higher compliance
  • No need to hide pills or worry about vomiting post-dose

Cons:

  • No heartworm or worm coverage
  • Cannot be undone if pet reacts poorly
  • Requires veterinary administration

Advertisements & Promos

Prediction for the Philippine Market

Injectables like Bravecto 365 are poised to gain dominance in urban centers, multi-pet households, and among time-strapped clients.

However, NexGard Spectra will maintain a stronghold, particularly among clients concerned with broad-spectrum parasite protection (especially heartworm prevention).

The most strategic approach for veterinarians is to offer both options and tailor recommendations based on:

  • Owner lifestyle
  • Pet temperament
  • Parasite risk in the area
  • Budget flexibility

Veterinary Insight: The Best of Both Worlds?

A possible trend in the Philippines could be:

  • Bravecto 365 + Annual Deworming & Heartworm test
  • Or, NexGard Spectra monthly + optional injectable flea/tick for high-risk seasons

Sources

  • Boehringer Ingelheim Global Product Reports (2024)
  • MSD Animal Health Bravecto 365 Product Launch Reports (2023–2024)
  • Veterinary Practice News USA (2023)
  • Australian Pesticide and Veterinary Medicines Authority (APVMA)

Advertisements & Promos

Sharing this helps others understand what it really means to be a veterinarian. Like and follow if you’re with us.

Dr. Geoff Carullo is a Fellow and the current President of the Philippine College of Canine Practitioners.

Advertisement

Share to your Network: